During 2023/24, Lloreda Camacho & Co. advised a string of multinational corporations on merger reviews, antitrust training sessions and day-to-day compliance matters, with Live Nation, Merck and Novo Nordisk among its representative clients. The group also has experience in contentious work, where it utilises its firm-wide strengths in life sciences and TMT to specialise in antitrust litigation and competition investigations pertaining to those sectors. Enrique Álvarez maintains a broad regulatory practice, which spans competition, life sciences and labour law — among others — and co-heads the group alongside established younger partner Darío Cadena. Associate Diego Matiz left to study abroad in September 2023.
L'éditorial du Legal 500
- Profil
Clients clés
- Merck Sharp & Dohme
- Merck Sharp & Dohme Animal Health
- Interpublic Group of Companies Colombia
- Seguros Bolívar
- Janssen
- Productos Roche
- Novo Nordisk
- Mobi.e
- Organon
- Promotora Colombia
Points forts
- Advised Live Nation on a merger review filing concerning its acquisition of certain assets from Paramo through OCESA.
- Represented Comcel (Claro Colombia) in a challenge against the National Communications Commission's decision to declare that Comcel has market power in the mobile voice and data market.
- Provided Productos Roche with a market power assessment of its Colombian portfolio.
Avocats
Les grands avocats du marché
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Responsable de la pratique
Enrique Álvarez; Darío Cadena